Using rTMS to enhance thinking in Veterans with Parkinson's disease
Official title: rTMS as a Cognitive Rehabilitation Approach in Veterans With Parkinson's Disease
Run by VA Office of Research and Development · NCT03836950 · Data updated 2026-11-12
This study is testing whether a non-invasive brain treatment called rTMS can help improve thinking skills in Veterans with Parkinson's disease who have mild cognitive issues.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 56 (estimated) |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 2 sites (Chicago, Illinois and 1 other locations) |
| Status | Recruiting |
| Started | April 1, 2020 |
| Main results expected | March 31, 2027 |
| Study ends | March 30, 2028 |
| Registry record updated | April 21, 2026 |
| Trial ID | NCT03836950 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Veterans aged 50 and older with a diagnosis of Parkinson's disease or atypical parkinsonism and mild cognitive impairment.
✕Probably not a fit
Patients with dementia, severe depression, or those who have undergone deep brain stimulation surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the safety and effectiveness of repetitive transcranial magnetic stimulation (rTMS) as a non-invasive treatment for Veterans suffering from Parkinson's disease or atypical parkinsonism with mild cognitive impairment. Participants will be randomly assigned to receive either active rTMS or a sham treatment, and their cognitive functions will be assessed through standardized tests at the beginning, end, and one month after the treatment. The study aims to explore changes in executive function and other cognitive domains, as well as brain connectivity using advanced neuroimaging techniques. By examining these effects, the research seeks to determine the potential of rTMS in improving cognitive outcomes for this population.
Why it matters
Potential benefit: If successful, this treatment could significantly enhance cognitive function and quality of life for Veterans with Parkinson's disease.
How similar studies have gone: While rTMS has shown promise in other cognitive rehabilitation contexts, this specific application in Parkinson's disease with mild cognitive impairment is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Veterans who seek services at Hines VA Hospital or Jesse Brown VA Medical Center
* Diagnosis of PD or atypical parkinsonism as determined by a neurologist
* Meet criteria for having mild cognitive impairment
* Receiving stable (i.e., no changes in medication and medication dose) medication and who are expected to remain on stable medication for the duration of the RCT
* Speak and read English
* 50 years or older
Exclusion Criteria:
* Dementia
* Failure to demonstrate decision making capacity
* History of deep brain stimulation surgery
* Severe depression
* Resting head tremor
* Dyskinesia that will interfere with collecting imaging data
* Has congestive heart failure
* Implanted cardiac pacemaker or defibrillator
* Cochlear implant, nerve stimulator, or intracranial metal clips
* Implanted medical pump
* Increased intracranial pressure
* History of claustrophobia
* Metal in eyes/face, shrapnel/bullet remnants in brain
* Participants at potential increased risk of seizure including those who have the following:
* history (or family history) of seizure or epilepsy
* history of stroke, head injury, or unexplained seizures
* presence of other neurological disease that may be associated with an altered seizure threshold
* such as CVA, cerebral aneurysm, dementia, increased intracranial pressure
* Concurrent medication use such as tricyclic antidepressants, neuroleptic medications, any other drug known to lower seizure threshold
* Secondary conditions that may significantly alter electrolyte balance or lower seizure threshold
* No quantifiable motor threshold such that rTMS dosage cannot be accurately deter-mined
Where it's running
-
Edward Hines Jr. VA Hospital, Hines, IL
Hines, Illinois, United States Recruiting -
Jesse Brown VA Medical Center, Chicago, IL
Chicago, Illinois, United States Not yet recruiting
Study contacts
- Principal investigator: Sandra L. Kletzel, PhD BA — Edward Hines Jr. VA Hospital, Hines, IL
- Study coordinator: Sandra L Kletzel, PhD BA
- Email: Sandra.Kletzel@va.gov
- Phone: (708) 202-5735
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Sound-based sleep stimulation to boost brain training in Parkinson's with mild cognitive impairment
This test will see if playing gentle, phase-targeted sounds during sleep together with a five-week home cognitive training program helps people with Parkinson's disease and mild cognitive impairment get more benefit from training.
-
Deep brain stimulation for cognitive issues in Parkinson's disease
This study is testing a new deep brain stimulation method to see if it can help improve thinking and movement problems in people with Parkinson's disease who have mild cognitive issues.
-
Imaging brain inflammation in neurodegenerative diseases
This study is testing how levels of certain proteins in the brain relate to neurodegenerative diseases like Alzheimer's and Parkinson's by comparing them in patients and healthy volunteers using brain scans.
-
Evaluating retinal imaging for neurodegenerative diseases
This study is testing if special eye scans can help spot early signs of neurodegenerative diseases like Alzheimer's and Parkinson's in people.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.